[Treatment of Salmonella infections with a new very broad spectrum bactericide. Analysis of 275 cases].
D000293:Adolescent; D000328:Adult; D000890:Anti-Infective Agents / Q000627:therapeutic use*; D002648:Child; D002675:Child, Preschool; D004357:Drug Synergism; D005260:Female; D005493:Folic Acid Antagonists / Q000627:therapeutic use*; D006801:Humans; D007223:Infant; D008297:Male; D010284:Paratyphoid Fever / Q000188:drug therapy; D011743:Pyrimidines / Q000627:therapeutic use*; D012480:Salmonella Infections / Q000188:drug therapy*; D013420:Sulfamethoxazole / Q000627:therapeutic use*; D014295:Trimethoprim / Q000627:therapeutic use; D014435:Typhoid Fever / Q000188:drug therapy
D000890:Anti-Infective Agents; D005493:Folic Acid Antagonists; D011743:Pyrimidines; D014295:Trimethoprim; D013420:Sulfamethoxazole
Traitement des Salmonelloses par un nouveau bactércide à très large spectre. Analyse de 275 observtions.